Free

Health Canada-US FDA Consultation on ICH (Live & Webcast)

Event Information

Share this event

Date and Time

Location

Location

Banting Theatre, Health Canada

Sir Frederick G. Banting Research Centre

251 Sir Frederick Banting Driveway

Ottawa, On K1A0K9

Canada

View Map

Friends Who Are Going
Event description

Description

The Canada-United States (U.S.) Regulatory Cooperation Council (RCC) was created in February 2011 to better align the two countries’ regulatory approaches, where possible.

Under the RCC initiative, Health Canada and the U.S. Food and Drug Administration (FDA) are holding joint public consultation meetings on International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use(ICH) guidelines currently under development. The aim of this initiative is to hold public consultation meetings prior to each bi-annual ICH face-to-face meeting, in order to seek input on areas of current regulatory disharmony and where harmonised ICH guidelines would be beneficial. Stakeholder input received through this initiative will be considered in current or future guideline development. Health Canada also intends to use these opportunities to better understand areas in drug product regulation where Canadian requirements may differ from those in place in the U.S., with a view to minimizing these differences.

The next ICH face-to-face meeting will take place in November 2017 in Geneva, Switzerland. In preparation for this meeting, a public consultation for Canadian and U.S. stakeholders under the RCC initiative will take place on October 19, 2017 9:00AM to 12:00PM, at the Tunney’s Pasture campus of Health Canada in Ottawa, Ontario. Future meetings will continue to alternate between Canada and the USA, with the next meeting (which is planned to be hosted by FDA) to occur in the Spring of 2018 prior to the next scheduled ICH meeting (which will be held in Kobe, Japan).

A draft agenda and list of guidelines currently under development or undergoing revision follows below. For additional information including Concept Papers and any available draft guidelines for comment please visit the ICH Website at http://www.ich.org/home.html.

In advance of the public meeting in October, Health Canada is also offering the opportunity for stakeholders to submit comments in writing for consideration by Health Canada and/or the US FDA. Comments will be accepted from the date of this Notice until October 16, 2017.

Please submit comments to the following email address:HPFB_ICH_DGPSA@hc-sc.gc.ca


**************

Draft Agenda

Health Canada - US FDA ICH Consultation

October 19, 2017 – 9:00AM – 12:00PM

1. Opening Remarks/Introductions

2. Overview of the ICH Process and ICH Reforms

3. Overview of MedDRA and MedDRA Points to Consider

4. Overview of Current Efficacy Topics

5. Overview of Current Safety Topics

6. Overview of Current Quality Topics

7. Overview of Current Electronic Standards Topics

8. Closing Remarks


Share with friends

Date and Time

Location

Banting Theatre, Health Canada

Sir Frederick G. Banting Research Centre

251 Sir Frederick Banting Driveway

Ottawa, On K1A0K9

Canada

View Map

Save This Event

Event Saved